Chipscreen Biosciences, Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Chipscreen Biosciences, Ltd.
RECRUITINGPhase 1NCT06902350
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
This trial is a single-arm, open-label, first-in-human study of CS231295, comprising two phases: dose escalation (including single-dose and multiple-dose) and cohort expansion....
Sponsor: Chipscreen Biosciences, Ltd.Enrolling: 1022 locations
NeoplasmsGlioblastoma, AdultSmall Cell Lung Carcinoma (SCLC)
RECRUITINGPhase 3NCT04921527
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
This randomized, double-blind, 2-arm study will evaluate the efficacy and safety of Chiauranib plus weekly paclitaxel versus placebo plus weekly paclitaxel in patients with...
Sponsor: Chipscreen Biosciences, Ltd.Enrolling: 4541 location
Ovarian CancerRelapsed or RefractoryChiauranib+1